Publication dates

Carcinoma Industry, July 2014 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, microbiology, more »


 
1-10 of 74 reports for Carcinoma

 Metastatic Renal Cell Carcinoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Metastatic Renal Cell Carcinoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Reasons to buy - evaluate the marketing status and exclusivity details of metastatic renal cell carcinoma key products to exploit opportunities for generic drug development ...

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... The report provides a snapshot of the global therapeutic landscape of recurrent head and neck cancer squamous cell carcinoma- the report reviews key pipeline products under drug profile section which ...

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2014

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... For the indicated disease.Scope- the report provides a snapshot of the global therapeutic landscape of transitional cell carcinoma (urothelial cell carcinoma)- the report reviews key ...

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2014

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... Therapeutic landscape of basal cell carcinoma (basal cell epithelioma)- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Targeted for various forms of cancer such as breast cancer (mcf-7/mdr), small-cell lung cancer (h69ar), uterine carcinoma (mes-sa/dx5) and pancreatic cancer (panc-1). The company also offers difluoro ...

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2014

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... Therapeutic landscape of gastroesophageal (ge) junction carcinomas- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Bladder Carcinoma - Pipeline Review, H1 2014

Bladder Carcinoma - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of bladder carcinoma- the report reviews key pipeline products under drug profile section which includes, product description, moa and r ...

Global Breast Cancer Market 2014-2018

Global Breast Cancer Market 2014-2018

  • $ 3 000
  • Industry report
  • June 2014
  • by Infiniti Research Limited

... Is the form of breast cancer which starts in the lining of the milk ducts while lobular carcinoma begins in the milk glands of the breast. When breast cancer spreads from the site of origin to surrounding ...

Pathology in United States: Hepatocellular Carcinoma – Pipeline Review, H1 2012

Pathology in United States: Hepatocellular Carcinoma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

... Of the hepatocellular carcinoma pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline productsreasons to buy ...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of adrenocortical carcinoma (adrenal cortex cancer)- the report reviews key pipeline products under drug profile section which includes, product description ...

About 2 100 reports for Carcinoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Pakistan and United Arab Emirates

  • Demographic Review, Clinical and Histological Presentation of Pa...
  • January 2012
    3 pages
  • Cancer  

    Carcinoma  

  • Pakistan  

    United Arab Emi...  

View report >

9 Companies for Carcinoma

Read our Company Profiles

Novartis Inc.

Switzerland

Eli Lilly and Co.

United States

Lilly and Co.

United States

Pfizer Inc.

United States

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.